Dr. Jennifer McVean, MD, is a distinguished pediatric endocrinologist and diabetes specialist dedicated to enhancing the lives of children and families affected by diabetes and endocrine disorders. Diagnosed with Type 1 diabetes at the age of 11, Dr. McVean brings a unique perspective to patient care, blending her personal journey with extensive medical expertise.
Currently serving as Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean has been instrumental in advancing pediatric diabetes care through clinical practice, research, education, and medical innovation. Her work has significantly contributed to the development of automated insulin delivery systems, such as the MiniMed™ 780G system, which aims to simplify diabetes management and improve patient outcomes. A recent study highlighted that the MiniMed™ 780G system reduces the burden of diabetes management by improving sleep and glycemic control overnight.
In addition to her role at Medtronic, Dr. McVean provides specialized pediatric endocrinology services at Hudson Physicians. She focuses on diagnosing and managing hormone-related conditions in children and adolescents, including Type 1 and Type 2 diabetes, growth concerns, and thyroid disorders. Her approach emphasizes empowering families with knowledge and tools to navigate the challenges of chronic disease management effectively.
Dr. McVean’s commitment extends beyond clinical practice. She actively participates in diabetes advocacy and educational organizations, such as the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA). Her involvement underscores her dedication to improving diabetes awareness, prevention, and treatment on a broader scale.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.